RaQualia Pharma Inc. (4579) Other
Market cap
¥22.3B
P/E ratio
-331.8x
Rakuoria Drug Discovery develops new pharmaceutical compounds through early-stage research and clinical trials, then licenses them to major pharmaceutical companies for revenue.
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Return on Assets | - | - | - | - | -7.3 | -4.1 | 8.9 | -5.7 | 12.1 | 2 | 15.9 | 12.6 | -3.1 | -1.9 | 8.4 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 81 | 81 | 70 | 70 | 64 | 50 | 60 | 63 | 68 | 70 | 67 | 65 | 67 | 85 | 85 |